BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 36409765)

  • 1. Gut microbiome in tumorigenesis and therapy of colorectal cancer.
    Wang L; Yu KC; Hou YQ; Guo M; Yao F; Chen ZX
    J Cell Physiol; 2023 Jan; 238(1):94-108. PubMed ID: 36409765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer.
    Fan X; Jin Y; Chen G; Ma X; Zhang L
    Digestion; 2021; 102(4):508-515. PubMed ID: 32932258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment.
    Liu Y; Lau HC; Cheng WY; Yu J
    Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):84-96. PubMed ID: 35914737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota in colorectal cancer development and therapy.
    Wong CC; Yu J
    Nat Rev Clin Oncol; 2023 Jul; 20(7):429-452. PubMed ID: 37169888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Microbiome in Carcinogenesis Process and Epigenetic Regulation of Colorectal Cancer.
    Farhana L; Banerjee HN; Verma M; Majumdar APN
    Methods Mol Biol; 2018; 1856():35-55. PubMed ID: 30178245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbe-based management for colorectal cancer.
    Gao ZY; Cui Z; Yan YQ; Ning LJ; Wang ZH; Hong J
    Chin Med J (Engl); 2021 Dec; 134(24):2922-2930. PubMed ID: 34855639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer and gut microbiota studies in China.
    Wang Z; Dan W; Zhang N; Fang J; Yang Y
    Gut Microbes; 2023; 15(1):2236364. PubMed ID: 37482657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer.
    Qu R; Zhang Y; Ma Y; Zhou X; Sun L; Jiang C; Zhang Z; Fu W
    Adv Sci (Weinh); 2023 Aug; 10(23):e2205563. PubMed ID: 37263983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Role of the Gut Microbiome In Colorectal Cancer Progression.
    Kim J; Lee HK
    Front Immunol; 2021; 12():807648. PubMed ID: 35069592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Male-Biased Gut Microbiome and Metabolites Aggravate Colorectal Cancer Development.
    Wang L; Tu YX; Chen L; Zhang Y; Pan XL; Yang SQ; Zhang SJ; Li SH; Yu KC; Song S; Xu HL; Yin ZC; Yue JQ; Ni QL; Tang T; Zhang JL; Guo M; Zhang S; Yao F; Liang XJ; Chen ZX
    Adv Sci (Weinh); 2023 Sep; 10(25):e2206238. PubMed ID: 37400423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of gut microbiota in the development of colorectal cancer: a review.
    Koyande N; Gangopadhyay M; Thatikonda S; Rengan AK
    Int J Colorectal Dis; 2022 Jul; 37(7):1509-1523. PubMed ID: 35704091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutraceuticals in colorectal cancer: A mechanistic approach.
    Rossi M; Mirbagheri SEYEDS; Keshavarzian A; Bishehsari F
    Eur J Pharmacol; 2018 Aug; 833():396-402. PubMed ID: 29935172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiome and its role in colorectal cancer.
    Rebersek M
    BMC Cancer; 2021 Dec; 21(1):1325. PubMed ID: 34895176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal vitamin D receptor protects against extraintestinal breast cancer tumorigenesis.
    Zhang YG; Xia Y; Zhang J; Deb S; Garrett S; Sun J
    Gut Microbes; 2023; 15(1):2202593. PubMed ID: 37074210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial Interactions and Interventions in Colorectal Cancer.
    Van Raay T; Allen-Vercoe E
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota and Colorectal Cancer Risk Factors.
    Feizi H; Rezaee MA; Ghotaslou R; Sadrkabir M; Jadidi-Niaragh F; Gholizadeh P; Taghizadeh S; Ghanbarov K; Yousefi M; Kafil HS
    Curr Pharm Biotechnol; 2023; 24(8):1018-1034. PubMed ID: 36200153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer.
    Fong W; Li Q; Yu J
    Oncogene; 2020 Jun; 39(26):4925-4943. PubMed ID: 32514151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial Metabolite Dysbiosis and Colorectal Cancer.
    Niekamp P; Kim CH
    Gut Liver; 2023 Mar; 17(2):190-203. PubMed ID: 36632785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Fusobacterium nucleatum in Colorectal Carcinogenesis.
    Datorre JG; de Carvalho AC; GuimarĂ£es DP; Reis RM
    Pathobiology; 2021; 88(2):127-140. PubMed ID: 33291114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commensal microbiota-derived metabolite agmatine triggers inflammation to promote colorectal tumorigenesis.
    Lu Y; Cui A; Zhang X
    Gut Microbes; 2024; 16(1):2348441. PubMed ID: 38706224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.